Maynard Um
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Oncolytics Biotech (ONCY)
-
-
-
-
-
-
-
Oncolytics reports clinical trial data for third-line anal cancer therapy
-
-
-
-
-
-
-
Oncolytics Biotech (ONCY) PT Raised to $10 at H.C. Wainwright
-
-
-
-
-
-
-
Oncolytics plans FDA talks for pancreatic cancer drug trial
-
-
-
-
-
-
-
Oncolytics Biotech (ONCY) Receives Nasdaq Non-compliance Notice
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Oncolytics Biotech (ONCY)
-
-
-
-
443,191 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

